WASHINGTON: US federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson’s Covi-19 vaccine after six women under 50 given the shot developed rare blood clots, dealing a fresh setback to efforts to tackle the pandemic. Following the news, Johnson & Johnson (J&J) said it was delaying the rollout of the vaccine to Europe, a week after regulators there said they were reviewing rare blood clots in four recipients of the shot in the United States. The moves come after European regulators said earlier this month they had found a possible link between AstraZeneca’s Covid-19 vaccine and a similar rare blood clotting problem that led to a small number of deaths.
Sanctions target Burhan’s leadership amid Sudan’s escalating civil war, condemning his role in indiscriminate attacks…
Deolira, born in 1905, is determined to secure the Guinness title as the world’s oldest…
Israeli Minister Itamar Ben-Gvir threatens to resign and withdraw his party, Otzma Yehudit, from the…
Donald Trump Jr’s Greenland event faced backlash after reports surfaced that homeless people were offered…
Initially thought to be human, the 20,000-year-old Ushikawa fossils were reclassified as bear bones after…
US officials are addressing a last-minute issue over prisoner identities in the Gaza ceasefire deal,…